Species and gender differences in the formation of an active metabolite of a substituted 2,4-thiazolidinedione insulin sensitizer

References

• AER.AWAL, A. and SHAPIRO, B. H., 2000, Differential expression of gender-dependent hepatic isoforms of cytochrome P-450 by pulse signals in the circulating masculine episodic growth hormone profile of the rat. Journal of Pharmacology and Experimental Therapeutics, 1, 228–237.
   Google Scholar
• BALI/WIN, .`5. 3., CA, A1USEandCiii ins, 5k. 3.,CMarakA,vi.waticycl GtlA1T (MA-1, TIASC1enzymes involved in the in vitro metabolism of rosiglitazone. British Journal of Clinical Pharmacology, 48, 424–432.
   Google Scholar
• BANHIERA, S., RYAN, D. E., LEVIN, W. and THOMAS, P. E., 1986, Age- and sex-related expression of cytochromes p450f and P450g in rat liver. Archives of Biochemistry and Biophysics, 2, 658–676.
   Google Scholar
• BERGFR, J., LEIBOWITZ, M. D., DOEBBER, T. W., EITIRECHT, A., ZANG, B., ZHOU, G., BISWAS, C., CULUNAN, C. A., HAYES, N. S., Li, Y., TANEN, M., VENTRE, j., 'h/u, M. S., BERGER, D., MosLEv, R., MARQuis, R., SANTINI, C., SAI100, S. P., Toi,mAN, R., SMITH, R. G. and 1\101,1,En, D., 1996, Novel peroxisome proliferator-activator receptor (PPAR) 7 and PPARS ligands produce distinct biological effects. Journal of Biological Chemistry, 274, 6718–6725.
   Google Scholar
• BERGEN, J. and MOLLER, D., 2002, The mechanisms of actions of PPARs. Annual Reviews of Medicine, 53, 409–435.
   PubMedGoogle Scholar
• BOLTON, G. C., KEOGH, J. P., EAST, P. D., HoL0s, F. J. and SHORE, A. D., 1996, The fate of a thiazolidinedione antidiabetic agent in rat and dog. Xenobiotica, 26, 627–636.
   Google Scholar
• BURT, R., PONSODA, X., JOVE R., GOMEZ-LEMON, M. J. and CASTELL, J. V., 1999, Diclofenac toxicity to hepatocytes: A role for drug metabolism in cell toxicity. journal of Pharmacology and Experimental Therapeutics, 288, 65–72.
   Google Scholar
• COOPER, K. 0., REIK, L. M., ZAID, J., BANDIERA, S., KEELEY, M., RYAN, D., DANIEL, R., MCCLUSKEY, S. A., LENIN, W. and THOMAS, P. E., 1993, Regulation of two members of the steroid-inducible cytochrome P450 subfamily (3A) in rats. Archives of Biochemistry and Biophysics, 301, 345–354.
   Google Scholar
• HASLER, J. A., EASTBROOK, R., MURRAY, M., PIKULEVA, I., WATERMAN, M., CAPDEVILA, J., VIJAKUMAR, H., HELVIG, C., FALCK, JR., FARRELL, G., KAMINSKY, L. S., SPIVACK, S. D., BOITIER, E. and BEAUNE, P., 1999, Human cytochromes P450. Molecular Aspects of Medicine, 20, 1–137.
   Google Scholar
• HENRY, R. R., 1997, Thiazolidinediones. Endocrinology and Metabolism Clinics of North America, 26, 553–573.
   PubMed Web of Science ®Google Scholar
• KAMATAKI, T., MAEDA, K., YAMAZOE, Y., NAGAI, T. and KATo, R., 1983, Sex difference of cytochrome P450 in the rat: purification, characterization and quantitation of constitutive forms of cytochrome P430 from liver microsomes of male and female rats. Archives of Biochemistry and Biophysics, 225, 758–770.
   PubMed Web of Science ®Google Scholar
• KAMATAKI, T., SHIMADA, M., MAEDA, K. and KATO, R., 1985, Pituitary regulation of sex-specific forms of cytochrome P450 in liver microsomes of rats. Biochemistry and Biophysics Research Communications, 130, 1247–1253.
   PubMed Web of Science ®Google Scholar
• KASSAIIUN, K., PEARSON, P. G., TANG, W., MCINTOSH, I., LEUNG, K., ELMORE, C., DEAN, D., WANG, R., Doss, G. and BAILLIE, T. A., 2001, Studies on the metabolism of troglitazone to reactive intermediates in vitro and in vivo. Evidence for novel biotransformation pathways involving quinone methide formation and thiazolidinedione ring scission. Chemical Research in Toxicology, 1, 62–70.
   Google Scholar
• KAWAI, K., KAWASAKI-TOKUI, Y., ODAKA, T., TSURUTA, F., KAZUI, M., INVABUCHI, H., NAKAMURA, T., KINOSHITA, T., IKEDA, T., YOSHIOKA, T., KOMAI, T. and NAKAMURA, K.-I., 1997, Disposition and metabolism of the new oral antidiabetic drug troglitazone in rats mice and dogs. Arzneim-ForschlDrug Research, 47, 356–368.
   Google Scholar
• KRIETER, PA., Coi.T.Evrt, A. E., Doss, G. A. and MILLER, R. R., 1994, Disposition and metabolism of the hypoglycemic agent pioglitazone in rats. Drug Metabolism and Disposition, 22, 623–630.
   Google Scholar
• LEGRAVEREND, C., MODE, A., WELLS, T., ROBINSON, I. and OUSTAESSON, j. A., 1992, Hepatic steroid hydroxylating enzymes are controlled by the sexually dimorphic pattern of growth hormone secretion in normal and dwarf rats. FASEB Journal, 2, 711–718.
   Google Scholar
• LEHMAN, J. M., MooRE, L. B., SMITH-OLIVER, TA., WILKINSON, W. 0., WILLSON, T. M. and KLIEWER, S. A., 1995, An antidiabetic thiazolidinedione is a high affinity ligand for peroxisome proliferator-activated receptor y (PPARy). Journal of Biological Chemistry, 270, 12933–12956.
   Google Scholar
• ODAKA, T., KAWAI, K., TSURUTA, F., IKEDA, T., KINOXHITA, T., NAKAMURA, M. and YAMAZOE, Y., 1995, Pharmacokinetics of troglitazone (CS-045), a new oral antidiabetic drug: Phase I and phase II metabolism in female rats. Xenobiotic Metabolism and Disposition, 10 (Suppl.), S386.
   Google Scholar
• PANG, K. S. and KWAN, K. C., 1983, A commentary: methods and assumptions in the kinetic estimation of metabolite formation. Drug Metabolism and Disposition, 11, 79–84.
   PubMed Web of Science ®Google Scholar
• PANG, J. M., ZALESKI, J. and KAUFFMAN, F. C., 1997, Toxicity of allyl alcohol in primary cultures of freshly isolated and cryopreserved hepatocytes maintained on hydrated collagen gels. Toxicology and Applied Pharmacology, 142, 87–94.
   PubMed Web of Science ®Google Scholar
• PHYSICIANS' DESK REFERENCE, 1999, RezulinTm. In Physicians' Desk Reference, 53rd edn (Montvale: Medical Economics), pp. 2310–2314.
   Google Scholar
• PUMFORD, N. R. and HALMES, N. C. 1997, Protein targets of xenobiotic reactive intermediates. Annual Reviews of Pharmacology and Toxicology, 37, 91–117.
   PubMed Web of Science ®Google Scholar
• RAUCY, J. L. and LASKER, J. M., 1991, Isolation of P450 enzymes from human liver. Methods in Enzymology, 206, 557–587.
   Google Scholar
• SHAPIRO, B. H., AGRAWAL, A. K. and PAMPORI, N. A., 1995 Gender differences in drug metabolism regulated by growth hormone. International Journal of Biochemistry and Cell Biology, 27, 9–20.
   PubMed Web of Science ®Google Scholar
• THOMAS, P. E., REIK, L. M., RYAN, D. E. and LEVIN, W., 1981, Regulation of three forms of cytochrome P450 and epoxide hydrolase in rat liver microsomes. Journal of Biological Chemistry, 25, 1044–1052.
   Google Scholar
• THUMMEL, K. E., FAVREAU, L. V., MoLE, J. E. and SCHENKMAN, J. B., 1988, Further characterization of RIAVI2 and comparison with a related form of cytochrome P-450, RLM2b. Archives of Biochemistry and Biophysics, 266, 319–333.
   PubMed Web of Science ®Google Scholar
• TORII, H., YOSHIDA, K., TSUKAMOTO, T. and TANAYAMA, S., 1984, Disposition in rats and dogs of ciglitazone, a new antidiabetic agent. Xenobiotica, 14, 259–268.
   PubMed Web of Science ®Google Scholar
• WATKINS, P. B. and WD1TcomB, R. W., 1998, Hepatic dysfunction associated with troglitazone. New England Journal of Medicine, 338, 916–917.
   Google Scholar
• WAXMAN, D. J., DANNAN, G. A. and GUENGERICH, F. P., 1985, Regulation of rat hepatic cytochrome P-430: age-dependent expression, hormonal imprinting, and xenobiotic inducibility of sex-specific isoenzymes. Biochemistry, 24, 4409–4417.
   PubMed Web of Science ®Google Scholar
• WAXMAN, D. J., RAM, P. A., PAMPORI, N. A. and SHAPIRO, B. H., 1995, Growth hormone regulation of male-specific rat liver P450s 2A2 and 3A2: induction by intermittent growth hormone pulses in male but not female rats rendered growth hormone deficient by neonatal monosodium glutamate. Molecular Pharmacology, 5, 790–797.
   Google Scholar
• YAMAZAKI, H., SHIBATA, A., SUZUKI, M., NAKAHMA, M., SHIMADA, N., GUENGLIERICH, F. P. and Yoko', T., 1999, Oxidation of troglitazone to a quinone-type metabolite catalyzed by cytochrome P450 2C8 and P450 3A4 in human liver microsomes. Drug Metabolism and Disposition, 27, 1260–1266.
   Google Scholar
• YAMAZOE, Y., MURAYAMA, N., SHIMADA, M., YAMAUCHI, K., NAGATA, K., 1MAOKA, S., FLINAE, Y. and KATO, R., 1988, A sex-specific form of cytochrome P-450 catalyzing propoxycoumarin 0-depropylation and its identity with testosterone 6 beta-hydroxylase in untreated rat livers: reconstitution of the activity with microsomal pigs. Journal of Biochemistry, 104, 785–790.
   Google Scholar
• YOSHIDA, K., 'loan, H., SUGIYAMA, Y., FLIJITA, T. and TANAYAMA, S., 1983, Rat-plasma metabolites of ciglitazone, a new antidiabetic agent. Xenobiatica, 14, 249–257.
   Google Scholar
• YOUNG, P. W., BUCKLE, D. R., CANTELLO, B. C. C., CHAPMAN, H., CLAPHAM, J. C., COYLE, P. J., HArcili, D., HINDLEY, R. M., HOLDER, J. C., KALLENDER, II., LATTER, A. J., LAWRIE, K. W., MOSSAKOWSKA, D., MURPHY, G. J., ROXBEE-COX, L. and SEIITII, S. A., 1998, Identification of high-affinity binding sites for the insulin sensitizer rosiglitazone (BRL-49653) in rodent and human adipocytes using a radioiodinated ligand for peroxisomal proliferator-activated receptor gamma. Journal of Pharmacology and Experimental Therapeutics, 284, 751–759.
   Google Scholar